16 results
management hematology diagnosis algorithm anticoagulation doac ibd malignancy mds thromboembolism venous anemia aplastic atopic atopy boweldisease candida candidemia candidiasis causes
Risk factor for VTE in cancer patients Tumor type • Very high risk: gastric, pancreas, brain •
Risk factor for ... VTE in cancer patients ... • Very high risk ... #RiskFactors #VTE ... #cancer #oncology
Treatment algorithm for VTE in Malignancy (A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... thrombosis in cancer ... patients at high risk ... of recurrent VTE ... Management #Hematology #Oncology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic ... diagnosis and risk-stratification ... • Risks: infection ... only curative treatment ... #hematology #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the treatment ... body mass index; VTE ... #DOAC #VTE #Malignancy ... Management #Hematology #Oncology
►
 Myelodysplastic Syndromes (MDS) What? Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
carries a variable risk ... factor (GCSF) treatments ... marrow studies Treatment ... and reducing the risk ... diagnosis #hematology #oncology
Duration of Treatment of Venous Thromboembolism (VTE) - Major transient risk factor (eg, major surgery, major
Duration of Treatment ... Thromboembolism (VTE ... Major transient risk ... or as long as cancer ... Indefinite #VTE
Post-Transplantation Lymphoproliferative Disorders (PTLD) Definition: Lymphoid and/or plasmacytic proliferations that occur as a result of immunosuppression in
for 21% of all cancers ... immunocompetent population Risk ... liver>kidney), EBV ... ↑ LDH), rising EBV ... Lymphoproliferative #Disorders #oncology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
Toxic injury to BM ... Parvovirus B19 - EBV ... • Hypocellular myelodysplastic ... aplastic anemia Treatment ... Aplastic #Anemia #oncology
Candidemia Workup and Management - IDSA Guidelines 1) Antibiotics • Empiric: Echinocandins (e.g. micafungin) for most patients
Other hardware - Risk-Benefit ... Generally no routine TTE ... unless clinical concern ... #candidiasis #treatment
Longterm Venous Thromboembolism Treatment Algorithm Treat for 3 months and reassess • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... at 3 Months • Cancer ... High Bleeding Risk ... therapy - Second VTE ... Thromboembolism #Treatment
No results found for "diabeticfoot risk ebm treatment oncology myelodysplastic vte cancer"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #diabeticfoot #risk #ebm #treatment #oncology #myelodysplastic #vte #cancer